David R. Boulware

21.3k total citations · 2 hit papers
294 papers, 10.3k citations indexed

About

David R. Boulware is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, David R. Boulware has authored 294 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 204 papers in Epidemiology, 199 papers in Infectious Diseases and 42 papers in Surgery. Recurrent topics in David R. Boulware's work include Fungal Infections and Studies (164 papers), Antifungal resistance and susceptibility (141 papers) and Nail Diseases and Treatments (54 papers). David R. Boulware is often cited by papers focused on Fungal Infections and Studies (164 papers), Antifungal resistance and susceptibility (141 papers) and Nail Diseases and Treatments (54 papers). David R. Boulware collaborates with scholars based in United States, Uganda and United Kingdom. David R. Boulware's co-authors include David B. Meya, Radha Rajasingham, Joshua Rhein, Paul R. Bohjanen, Tom Chiller, Nelesh P. Govender, David W. Denning, Angela Loyse, Benjamin J. Park and Nathan C. Bahr and has published in prestigious journals such as New England Journal of Medicine, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

David R. Boulware

279 papers receiving 10.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis

2017 1.3k citations Radha Rajasingham, Joseph N Jarvis et al. profile →
The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis

2022 298 citations Radha Rajasingham, Nelesh P. Govender et al. profile →

Peers

Countries citing papers authored by David R. Boulware

Since Specialization

Citations

This map shows the geographic impact of David R. Boulware's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Boulware with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Boulware more than expected).

Fields of papers citing papers by David R. Boulware

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Boulware. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Boulware. The network helps show where David R. Boulware may publish in the future.

Co-authorship network of co-authors of David R. Boulware

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Boulware. A scholar is included among the top collaborators of David R. Boulware based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Boulware. David R. Boulware is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Postmortem Analysis of Dolutegravir, Tenofovir, Lamivudine, and Efavirenz Penetration in Multiple Central Nervous System Compartments 2024 ·The Journal of Infectious Diseases ·Fan Wang, (unknown), (unknown), (unknown), James Fisher, David B. Meya, MaryPeace McRae, David R. Boulware, Robert Lukande, Melanie R. Nicol	2
2	Cerebrospinal Fluid Cytokines and Chemokines Involved in Cytotoxic Cell Function and Risk of Acute 14-Day Mortality in Persons with Advanced HIV and Cryptococcal Meningitis 2024 ·The Journal of Infectious Diseases ·Elizabeth C Okafor, Liliane Mukaremera, Kathy Huppler Hullsiek, Nicole Engen, Lillian Tugume, Kenneth Ssebambulidde, Abdu K Musubire, Edwin Nuwagira, Edward Mpoza, Darlisha A Williams, Conrad Muzoora, Joshua Rhein, David B. Meya, Kirsten Nielsen, David R. Boulware	1
3	Infectious Diseases Physician Management of Cryptococcal Meningitis in North America—Is Single High-Dose Liposomal Amphotericin B Being Used? 2024 ·Open Forum Infectious Diseases ·Nathan C. Bahr, Susan E. Beekmann, Philip M. Polgreen, (unknown), Andrej Spec, David R. Boulware, John W. Baddley	4
4	A Comparison of Recruitment Methods for a Remote, Nationwide Clinical Trial for COVID-19 Treatment 2024 ·Open Forum Infectious Diseases ·Katrina M Hartman, (unknown), Via Rao, Aubrey A Hagen, Hanna G Saveraid, Regina Fricton, Samuel Lee, (unknown), Matthew F Pullen, David R. Boulware, David Liebovitz, Hrishikesh Belani, (unknown), Thomas A. Murray, Ken Cohen, Jennifer L. Thompson, Spencer M Erickson, Carolyn T. Bramante	0
5	The importance of appropriate selection of clinical endpoints in outpatient COVID-19 clinical trials 2023 ·SHILAP Revista de lepidopterología ·Kristian Thorlund, Davey M. Smith, (unknown), Nicholas J. White, Christopher Butler, David R. Boulware, Judith S. Currier, Ofir Harari, (unknown), Nathalie Strub‐Wourgaft, Stacey J. Adam, Edward J. Mills	5
6	Advancing Diagnosis and Treatment in People Living with HIV and Tuberculosis Meningitis 2023 ·Current HIV/AIDS Reports ·(unknown), (unknown), (unknown), (unknown), (unknown), Enock Kagimu, Morris K Rutakingirwa, Kristoffer E. Leon, Felicia C. Chow, Sean Wasserman, David R. Boulware, Fiona V Cresswell, Nathan C. Bahr	2
7	Strategies for Expediting Clinical Trials in the Next Public Health Emergency 2023 ·JAMA Health Forum ·Boghuma K Titanji, David R. Boulware, Rachel Bender Ignacio	3
8	Hyponatremia as a Predictor of Cryptococcal Meningitis and Death Among Asymptomatic Persons With HIV and Cryptococcal Antigenemia 2023 ·Open Forum Infectious Diseases ·(unknown), Elizabeth Nalintya, (unknown), Paul Kirumira, (unknown), (unknown), (unknown), Caleb P Skipper, David B. Meya, David R. Boulware, Radha Rajasingham	2
9	Baseline Cytomegalovirus Viremia at Cryptococcal Meningitis Diagnosis Is Associated With Long-term Increased Incident TB Disease and Mortality in a Prospective Cohort of Ugandan Adults With HIV 2023 ·Open Forum Infectious Diseases ·Jayne Ellis, Ananta Bangdiwala, Caleb P Skipper, Lillian Tugume, (unknown), (unknown), Katelyn A Pastick, Kenneth Ssebambulidde, Bożena M Morawski, Abdu K Musubire, Mark R. Schleiss, David Moore, Joseph N Jarvis, David R. Boulware, David B. Meya, Barbara Castelnuovo	3
10	Pregnancy-Related Tuberculous Meningitis and Immune Reconstitution Inflammatory Syndrome: A Case Series and Systematic Review 2022 ·Open Forum Infectious Diseases ·Katelyn A Pastick, Enock Kagimu, (unknown), Kenneth Ssebambulidde, (unknown), (unknown), (unknown), David B. Meya, David R. Boulware, Fiona V Cresswell, Nathan C. Bahr	4
11	Evaluation of the effectiveness of a South African laboratory cryptococcal antigen screening programme using a retrospective cohort and a cluster-randomised trial design 2022 ·BMJ Open ·(unknown), Ananta Bangdiwala, Erika van Schalkwyk, Caleb P Skipper, Greg Greene, (unknown), Kathy Huppler Hullsiek, (unknown), Radha Rajasingham, David R. Boulware, Nelesh P. Govender	2
12	Therapeutic Lumbar Punctures in Human Immunodeficiency Virus–Associated Cryptococcal Meningitis: Should Opening Pressure Direct Management? 2022 ·Open Forum Infectious Diseases ·Enock Kagimu, Nicole Engen, Kenneth Ssebambulidde, John Kasibante, (unknown), Edward Mpoza, Lillian Tugume, Edwin Nuwagira, (unknown), Darlisha A Williams, Kathy Huppler Hullsiek, David R. Boulware, David B. Meya, Joshua Rhein, Mahsa Abassi, Abdu K Musubire	11
13	Cerebrospinal Fluid Lactate as a Prognostic Marker of Disease Severity and Mortality in Cryptococcal Meningitis 2020 ·Clinical Infectious Diseases ·Mahsa Abassi, Ananta Bangdiwala, Edwin Nuwagira, Kiiza Kandole Tadeo, Michael Okirwoth, Darlisha A Williams, Edward Mpoza, Lillian Tugume, Kenneth Ssebambulidde, Kathy Huppler Hullsiek, Abdu K Musubire, Conrad Muzoora, Joshua Rhein, David B. Meya, David R. Boulware	16
14	Landmark clinical observations and immunopathogenesis pathways linked to HIV and Cryptococcus fatal central nervous system co‐infection 2020 ·Mycoses ·(unknown), David R. Boulware, Joseph Olobo, David B. Meya	22
15	Tuberculosis in HIV-Associated Cryptococcal Meningitis is Associated with an Increased Risk of Death 2020 ·Journal of Clinical Medicine ·Morris K Rutakingirwa, Fiona V Cresswell, Richard Kwizera, Kenneth Ssebambulidde, Enock Kagimu, Edwin Nuwagira, Lillian Tugume, Edward Mpoza, (unknown), Darlisha A Williams, Conrad Muzoora, David B. Meya, David R. Boulware, Kathy Huppler Hullsiek, Joshua Rhein	14
16	Identification of Pathogen Genomic Differences That Impact Human Immune Response and Disease during Cryptococcus neoformans Infection 2019 ·mBio ·Aleeza C. Gerstein, (unknown), Tami McDonald, Yina Wang, (unknown), (unknown), Kyle D. Smith, Andrew Akampurira, David B. Meya, Chaoyang Xue, David R. Boulware, Kirsten Nielsen	41
17	The Mouse Inhalation Model of Cryptococcus neoformans Infection Recapitulates Strain Virulence in Humans and Shows that Closely Related Strains Can Possess Differential Virulence 2019 ·Infection and Immunity ·Liliane Mukaremera, Tami McDonald, Judith N. Nielsen, (unknown), Andrew Akampurira, Charlotte Schutz, Kabanda Taseera, Conrad Muzoora, Graeme Meintjes, David B. Meya, David R. Boulware, Kirsten Nielsen	41
18	Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysis 2019 ·PLoS ONE ·Radha Rajasingham, David B. Meya, Greg Greene, Alexander Jordan, (unknown), Tom Chiller, David R. Boulware, Bruce A. Larson	34
19	The Cryptococcus neoformans Transcriptome at the Site of Human Meningitis 2014 ·mBio ·Yuan Chen, Dena L. Toffaletti, Jennifer L. Tenor, Anastasia P. Litvintseva, (unknown), Thomas G. Mitchell, Tami McDonald, Kirsten Nielsen, David R. Boulware, Tihana Bicanic, John R. Perfect	84
20	Cryptococcal Genotype Influences Immunologic Response and Human Clinical Outcome after Meningitis 2012 ·mBio ·Darin L. Wiesner, (unknown), Jennifer Corcoran, Tami McDonald, Melissa A. Rolfes, David B. Meya, Henry Kajumbula, Andrew Kambugu, Paul R. Bohjanen, Joseph Knight, David R. Boulware, Kirsten Nielsen	72

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact